Obstructive sleep apnea (OSA) is linked to increased risk of ST-segment elevation myocardial infarction (STEMI) during the night, with this study examining the timing and frequency of STEMI occurrences in OSA patients compared to non-OSA patients.
In a study of 397 patients, 33% of those with OSA experienced STEMI onset between midnight and 5:59 am, significantly higher than the 15% in non-OSA patients, indicating a nearly threefold increased risk of STEMI during these hours for OSA patients.
Over a follow-up period of nearly three years, STEMI onset times in OSA patients were associated with a heightened risk of adverse cardiovascular and cerebrovascular events
The study investigated left ventricular remodeling (LVR) in patients with acute STEMI who were treated with primary percutaneous coronary intervention (PCI), focusing on the connection between early left ventricular dilation and later LVR outcomes.
Out of 301 patients, 18.9% experienced LVR, with significant differences in left ventricular end-diastolic volume (LVEDV) changes between those with LVR and those without during follow-up.
Early measurement of changes in LVEDV after discharge and at 1 month was effective in predicting late LVR at the 6-month mark, suggesting that consistent monitoring may improve patient outcomes.
The study aimed to evaluate the effectiveness of [Ga]Ga-DOTA-FAPI-04 PET/MR imaging in predicting late left ventricular (LV) remodeling in patients who experienced a ST-segment elevation myocardial infarction (STEMI).
Twenty-six STEMI patients underwent [Ga]Ga-DOTA-FAPI-04 PET/MR scans at the start and about 12 months later, looking for an increase in LV end-systolic volume (LVESV) as a marker of LV remodeling.
Results showed that higher baseline uptake of [Ga]Ga-DOTA-FAPI-04 was linked to an increased risk of LV remodeling, with this imaging technique proving more predictive than conventional clinical assessments and imaging methods.